Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ocular Hypertension (OHT)”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Testing effectiveness (Phase 2)Study completedNCT02742649
What this trial is testing

Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
ForSight Vision5, Inc. 55
Not applicableStudy completedNCT01628588
What this trial is testing

Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 854
Not applicableWithdrawnNCT04064918
What this trial is testing

Effects of Netarsudil and Timolol on Retinal Blood Vessel Density and Visual Acuity

Who this might be right for
OAG - Open-Angle GlaucomaOHT - Ocular Hypertension
University of California, San Diego
Not applicableStudy completedNCT01540370
What this trial is testing

Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 102
Not applicableStudy completedNCT01628614
What this trial is testing

Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 4,812
Testing effectiveness (Phase 2)Study completedNCT06249152
What this trial is testing

Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients

Who this might be right for
Open-angle Glaucoma (OAG)Ocular Hypertension (OHT)Glaucoma
Qlaris Bio, Inc. 36
Large-scale testing (Phase 3)Ended earlyNCT02801617
What this trial is testing

Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Laboratorios Sophia S.A de C.V. 116
Testing effectiveness (Phase 2)Study completedNCT03233308
What this trial is testing

Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Primary Open Angle Glaucoma or Ocular Hypertension
Aerie Pharmaceuticals 20
Large-scale testing (Phase 3)Study completedNCT02981446
What this trial is testing

A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT

Who this might be right for
Open Angle Glaucoma or Ocular Hypertension
Santen Pharmaceutical Co., Ltd. 370
Large-scale testing (Phase 3)Looking for participantsNCT07354516
What this trial is testing

Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
OAG - Open-Angle GlaucomaOHT - Ocular Hypertension
Qlaris Bio, Inc. 60
Large-scale testing (Phase 3)Study completedNCT04620135
What this trial is testing

Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Aerie Pharmaceuticals 245
Testing effectiveness (Phase 2)Study completedNCT01896180
What this trial is testing

Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost

Who this might be right for
Primary Open Angle GlaucomaOcular HypertensionElevated Intraocular Pressure
Alleanza Pharmaceuticals, Inc. 63
Not applicableStudy completedNCT01568008
What this trial is testing

Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Allergan 933
Not applicableStudy completedNCT01864642
What this trial is testing

Effects of a Single OMT on Intraocular Pressure (IOP) in Ocular Hypertenive or Glaucoma Suspect Subjects

Who this might be right for
Ocular HypertensionGlaucoma
University of Wisconsin, Madison 28
Large-scale testing (Phase 3)Study completedNCT00051142
What this trial is testing

A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Alcon Research
Post-approval studies (Phase 4)UnknownNCT01125306
What this trial is testing

Efficiency of XAL-EASE Device in Glaucoma and/or Ocular Hypertension (OHT) Patients, Treated With Xalatan or Xalacom

Who this might be right for
GlaucomaHypertension
Meir Medical Center 50
Not applicableLooking for participantsNCT07408154
What this trial is testing

Direct vs Standard SLT for Glaucoma: A Noninferiority Trial

Who this might be right for
Open-angle Glaucoma (OAG)Ocular Hypertension (OHT)
Medical University of South Carolina 172
Early research (Phase 1)Not Yet RecruitingNCT07641296
What this trial is testing

Evaluation of the Safety, Efficacy, Dose Response of the Bimatoprost Drug Ring System (BIM-DRS) in Pseudophakic Patients Diagnosed With Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
GlaucomaOcular Hypertension
SpyGlass Pharma, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT02140060
What this trial is testing

6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
GlaucomaOcular Hypertension
Alcon Research 327
Large-scale testing (Phase 3)Study completedNCT00691717
What this trial is testing

Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOular Hypertension
Alcon Research 201
Load More Results